REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH)
CUSIP: 76152G100
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 13,730,837
- Total 13F shares
- 2,612,910
- Share change
- +9,829
- Total reported value
- $7,543,000
- Price per share
- $2.89
- Number of holders
- 11
- Value change
- -$15,645
- Number of buys
- 5
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76152G100:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
8.7%
|
1,200,000
|
$4,884,000 | — | 30 Sep 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
4.6%
|
630,700
|
$2,567,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
509,056
|
$2,072,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
76,964
|
$313,000 | — | 30 Sep 2021 | |
| EMC Capital Management |
13F
|
Company |
0.55%
|
75,835
|
$265,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.24%
|
33,470
|
$136,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
26,635
|
$108,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
24,806
|
$101,000 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.1%
|
13,453
|
$54,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
10,584
|
$43,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,578
|
$6,000 | — | 30 Sep 2021 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) as of Q4 2021
As of 31 Dec 2021,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,612,910 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EMC Capital Management, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., NORTHERN TRUST CORP, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and Tower Research Capital LLC (TRC).
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
11
Q4 2021 holders
11
Holder diff
0
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.